# Nivagen Pharmaceuticals Inc – FDA Inspection, Mar 20, 2024

Source: https://www.keypedia.com/records/fda_inspections/nivagen-pharmaceuticals-inc/c0261737-388a-454c-91fe-25945978d9a6
Source feed: FDA_Inspections

> FDA inspection 1236732 of Nivagen Pharmaceuticals Inc, March 20, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1236732
- Company Name: Nivagen Pharmaceuticals Inc
- Inspection Date: 2024-03-20
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Company Rep](https://www.keypedia.com/people/humberto-z-gomez/6de682f6-ae2a-45ff-92ab-ba6ac7bb97b4)

Company: https://www.keypedia.com/companies/nivagen-pharmaceuticals-inc/f864fdcc-3906-44c6-9379-e5d36d15dd32

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
